In-hospital mortality rates for coronary artery disease patients following PCI remain within international benchmarks
PCI mortality rates in Asia-Pacific region within international benchmarks
This meta-analysis of 27 studies across 16 registries in the Asia-Pacific region reports in-hospital mortality rates between 0.26% and 2.80%…
A large meta-analysis finds in-hospital death rates after PCI in Asia-Pacific range from 0.26% to 2.80%, with most around 0.9-1.6%.
Heart-healthy dietary interventions do not significantly alter serum Lp(a) concentrations in children
Heart-Healthy Diet Does Not Lower Lp(a) in Children
This RCT of 1062 healthy children found that median serum Lp(a) increased from infancy until age 13. While a heart-healthy diet was tested, …
A heart-healthy diet barely budges Lp(a) in kids. The real surprise? Lp(a) levels track strongly from infancy.
Impella CP Reduces Escalation Need in STEMI Cardiogenic Shock
Trial shows micro-axial flow pump reduces escalation rates
In non-comatose STEMI cardiogenic shock patients, Impella CP reduced escalation to higher tMCS vs standard care, but escalated patients had …
A new analysis shows that using a specific heart pump can delay the need for more invasive treatments in patients with severe heart failure.
FDA Approves Eliquis (apixaban) for Reducing Stroke Risk in Nonvalvular Atrial Fibrillation
FDA approves Eliquis to prevent strokes and treat blood clots.
The FDA approved Eliquis (apixaban) to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. It …
The FDA approved Eliquis (apixaban) to reduce stroke risk in people with atrial fibrillation and to treat or prevent blood clots. This pill …
Finerenone reduces mortality and heart failure risk (HR 0.644) in post-AMI patients
Finerenone may lower heart failure risk after heart attack
This retrospective cohort study of 1,012 adult patients with AMI found that finerenone initiation within 6 months was associated with a lowe…
A new look at real-world data suggests the drug finerenone could protect hearts and kidneys in patients following a heart attack.
Complete LVA ablation shows no arrhythmia-free survival benefit in persistent AF
Complete LVA Ablation Shows No Extra Benefit for AF
This post hoc subanalysis of an RCT compared complete low-voltage area (LVA) ablation versus no LVA ablation in 341 patients with persistent…
Adding complete low-voltage area ablation to standard AF treatment didn't improve outcomes in a new analysis.
Elevated troponin levels are associated with increased risk of MACE and all-cause mortality in ICI-associated myocarditis
Troponin levels help identify heart inflammation in cancer patients
This meta-analysis evaluates the performance of cardiac troponin as a biomarker for identifying immune checkpoint inhibitor (ICI)-associated…
A new look at cardiac troponin shows it can help doctors spot and predict serious heart risks for patients on certain cancer treatments.
Natural products like polyphenols and berberine modulate gut microbiota to target atherosclerosis pathways
Natural products may target gut health to impact heart disease
This narrative review explores how natural products, including polyphenols and berberine, influence the gut microbiota-metabolite-vascular a…
Certain natural compounds like berberine and polyphenols may help manage atherosclerosis by improving gut health and reducing inflammation.
Additional ablation after PVI improves AF freedom in non-diabetics but not in diabetics
Extra ablation may not help diabetes patients with atrial fibrillation
A subanalysis of an RCT in 493 patients undergoing catheter ablation for persistent AF found that adding linear and/or CFAE ablation to PVI …
For people with diabetes and atrial fibrillation, adding extra ablation beyond standard PVI may not lower recurrence risk.
Real-time heart team decision making maintains noninferiority of 1-year MACCE in complex CAD
Real-time heart team meetings improve care for coronary artery disease
This randomized controlled trial of 490 patients with de novo left main or 3-vessel coronary artery disease found that real-time heart team …
A new way of coordinating heart teams during surgery can cut patient wait times and costs without changing clinical safety outcomes.
Pulsed field ablation beats antiarrhythmic drugs as first-line persistent AF therapy
Pulsed field ablation shows higher success than drugs for heart rhythm
In a randomized trial of 207 patients with previously untreated persistent atrial fibrillation, pulsed field ablation (PFA) achieved 56% tre…
A new trial shows pulsed field ablation provides a much higher success rate than standard drugs for patients with persistent atrial fibrilla…
Specific reversal agents offer high-affinity neutralization but face cost and access barriers in thromboembolism management
New Options and Challenges for Reversing Blood Clot Treatments
This systematic review evaluates procoagulant strategies including specific reversal agents like idarucizumab and non-specific options for t…
Doctors are evaluating specific and non-specific agents to safely reverse the effects of anticoagulant medications in patients with blood cl…